Brief: Vivesto Announces Positive Paccal Vet FDA Pre-Submission Meeting
June 16 (Reuters) - Vivesto AB VIVE.ST :
* VIVESTO ANNOUNCES POSITIVE PACCAL VET FDA PRE-SUBMISSION
MEETING
* VIVESTO PLANS TO START PILOT STUDY IN SECOND HALF OF 2023
Source text for Eikon: ID:nMFNDT8mD
Further company coverage: VIVE.ST
(Gdansk Newsroom)
((gdansk.newsroom@thomsonreuters.com; +48 58 769 66 00;))
Recent news on Vivesto AB
See all newsBrief: Vivesto Reports Positive Topline Results From Paccal Vet Study In Cats
Brief: Vivesto Says Topline Results For Paccal Vet 'Positive'
Brief: Vivesto Q2 Operating Loss At SEK 8.6 Mln
Brief: Vivesto: Positive Results From Exploratory Study With Cantrixil
Brief: Vivesto Appoints Björn Svanström As CFO